f-star Raises Series A

f-star, a Vienna, Austria-based antibody engineering company, has raised EUR6 million in Series A funding from Aescap Venture and Atlas Venture. F-star had previously raised EUR1.5 million in seed funding from Atlas, and another EUR3.5 million in loans and grants from Austrian government agencies. www.f-star.com